Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose

Oncology Reports

Volumn 29, Issue 5, 2013, Pages 2053-2057

  Miwa, Hiroshi ^a   Shikami, Masato ^a   Goto, Mineaki ^a   Mizuno, Shohei ^a   Takahashi, Miyuki ^a   Tsunekawa Imai, Norikazu ^a   Ishikawa, Takamasa ^b   Mizutani, Motonori ^a   Horio, Tomohiro ^a   Gotou, Mayuko ^a   Yamamoto, Hidesuke ^a   Wakabayashi, Motohiro ^a   Watarai, Masaya ^a   Hanamura, Ichiro ^a   Imamura, Akira ^a   Mihara, Hidetsugu ^a   Nitta, Masakazu ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Keio University and Human Metabolome Technologies Inc   (Japan)

Author keywords

2 deoxyglucose; Acute myelogenous leukemia; Carnitine; Glutathione; Glycolysis; Metabolome; Pentose phosphate pathway

Indexed keywords

ACETYLCARNITINE; CARNITINE; DEOXYGLUCOSE; GLUTATHIONE SYNTHASE; TRICARBOXYLIC ACID;

ARTICLE; CELL GROWTH; CONTROLLED STUDY; ENERGY YIELD; ENZYME INHIBITION; ENZYME SYNTHESIS; FATTY ACID OXIDATION; GLYCOLYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; METABOLOME; MITOCHONDRION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ACETYL COENZYME A; AMP-ACTIVATED PROTEIN KINASES; CARNITINE O-PALMITOYLTRANSFERASE; CELL LINE, TUMOR; CITRIC ACID CYCLE; DEHYDROEPIANDROSTERONE; DEOXYGLUCOSE; ENERGY METABOLISM; FATTY ACIDS; GLUCOSE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLYCOLYSIS; HUMANS; LEUKEMIA; METABOLOME; MITOCHONDRIA; NADP; OXIDATION-REDUCTION; OXIDATIVE PHOSPHORYLATION; PENTOSE PHOSPHATE PATHWAY; PYRAZOLES; PYRIMIDINES;

EID: 84876267967     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2299     Document Type: Article

References (17)

1. Warburg O: On the origin of cancer cells. Science 123: 309-314, 1956.
2. Gatenby RA and Gillies RJ: Why do cancers have high aerobic glycolysis? Nat Rev Cancer 4: 891-899, 2004. (Pubitemid 39472955)
3. Pelicano H, Martin DS, Xu RH and Huang P: Glycolysis inhibition for anticancer treatment. Oncogene 25: 4633-4646, 2006. (Pubitemid 44187614)
4. El Mjiyad N, Caro-Maldonado A, Ramírez-Peinado S and Muñoz-Pinedo C: Sugar-free approaches to cancer cell killing. Oncogene 30: 253-264, 2011.
5. Sols A and Crane RK: Substrate specificity of brain hexokinase. J Biol Chem 210: 581-595, 1954.
6. Kurtoglu M, Gao N, Shang J, Maher JC, Lehrman MA, Wangpaichitr M, Savaraj N, Lane AN and Lampidis TJ: Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol Cancer Ther 6: 3049-3058, 2007. (Pubitemid 350206783)
7. Tennant DA, Durán RV and Gottlieb E: Targeting metabolic transformation for cancer therapy. Nat Rev Cancer 10: 267-277, 2010.
8. Porporato PE, Dhup S, Dadhich RK, Copetti T and Sonveaux P: Anticancer targets in the glycolytic metabolism of tumors: a comprehensive review. Front Pharmacol 2: 49, 2011.
9. Cheong H, Lu C, Lindsten T and Thompson CB: Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol 30: 671-678, 2012.
10. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, De Young LR and Lampidis TJ: 2-Deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 64: 31-34, 2004. (Pubitemid 38114078)
11. Singh D, Banerji AK, Dwarakanath BS, Tripathi RP, Gupta JP, Mathew TL, Ravindranath T and Jain V: Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme. Strahlenther Onkol 181: 507-514, 2005. (Pubitemid 41059520)
12. Ooga T, Sato H, Nagashima A, Sasaki K, Tomita M, Soga T and Ohashi Y: Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia. Mol Biosyst 7: 1217-1223, 2011.
13. Suganuma K, Miwa H, Imai N, Shikami M, Gotou M, Goto M, Mizuno S, Takahashi M, Yamamoto H, Hiramatsu A, Wakabayashi M, Watarai M, Hanamura I, Imamura A, Mihara H and Nitta M: Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation. Leuk Lymphoma 51: 2112-2119, 2010.
14. 31P NMR and metabolic implications. Biochimie 74: 867-873, 1992.
15. Sandulache VC, Ow TJ, Pickering CR, Frederick MJ, Zhou G, Fokt I, Davis-Malesevich M, Priebe W and Myers JN: Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells. Cancer 117: 2926-2938, 2011.
16. Hardie DG and Pan DA: Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30: 1064-1070, 2002. (Pubitemid 36002407)
17. Jeon SM, Chandel NS and Hay N: AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature 485: 661-665, 2012.